Identification of positional isomers of linoleic acid containing phospholipids involved in pancreatic ductal adenocarcinoma

Significance of the Topic

Accurate identification of lipid isomers, particularly the position of double bonds in fatty acyl chains, is critical for understanding biological functions and disease mechanisms. In pancreatic ductal adenocarcinoma (PDAC), changes in serum phospholipid composition have been linked to disease progression. Conventional collision-induced dissociation (CID) often fails to assign precise C=C locations, limiting the structural resolution of lipid biomarkers.

Objectives and Study Overview

This work applied Oxygen Attachment Dissociation (OAD) MS/MS alongside CID on a high-resolution QTOF platform to re-examine candidate lipid biomarkers of PDAC. The study aimed to assign double bond positions in linoleic acid–containing phospholipids previously flagged by untargeted metabolomics and to compare profiles between PDAC patient sera and healthy controls.

Materials and Methods

A reversed-phase LC separation was performed on an Acquity C18 BEH column (2.1×100 mm, 1.7 µm) at 50 °C, with a water/acetonitrile gradient containing 0.1 % formic acid. Eluted lipids were analyzed on a Shimadzu LCMS-9050 QTOF with simultaneous CID and OAD MS/MS in both positive and negative ESI modes. Data-dependent acquisition (DDA) selected precursor ions for MS/MS (m/z 40–1250) with collision energy spread of 6–30 V. OAD radicals (O, OH, H) generated by microwave discharge in vacuum were introduced to oxidize and fragment C=C sites. LabSolutions Insight software processed the data and assigned omega (n-) and delta (Δ) double bond positions.

Main Results and Discussion

OAD MS/MS enabled clear identification of positional isomers for phosphatidylcholine and phosphatidylethanolamine species containing linoleic acid (18:2). Key findings included:

• Successful localization of n-6 and n-9 double bonds in PC(18:2/0:0), PE(18:2/0:0), PC(18:1_18:2), PC(18:2_18:2) and PC(20:4_18:2).
• Demonstration that several omega-6 linoleic acid–containing species were significantly reduced in PDAC patient serum relative to healthy controls.
• Structural characterization of LPC(20:5/0:0) and LPE(18:1/0:0), confirming double bond placements at n-9 and multiple n-positions for polyunsaturated chains.

OAD-specific fragment ions provided complementary information to CID, simplifying spectral interpretation and increasing confidence in C=C assignments.

Contributions and Practical Applications

The integration of OAD MS/MS into lipidomics workflows offers:

• Enhanced structural elucidation of lipid isomers without extensive sample derivatization.
• Improved reliability in biomarker discovery for cancer research through precise double bond localization.
• A rapid, high-throughput approach compatible with existing CID-based methods.

Future Trends and Applications

OAD MS/MS is poised to become a standard tool in lipidomics, enabling:

• Broader use in clinical and translational studies of metabolic diseases and cancer.
• Combination with ion mobility and other fragmentation techniques for multidimensional lipid characterization.
• Development of diagnostic assays leveraging isomer-specific lipid signatures.

Conclusion

OAD MS/MS on a high-resolution QTOF platform provides a robust approach for C=C positional mapping in complex lipid mixtures. Its ability to generate unique radical-induced fragments enhances the structural resolution of lipid biomarkers, offering new insights into lipid alterations in PDAC.

Used Instrumentation

• Shimadzu LCMS-9050 QTOF Mass Spectrometer with simultaneous CID and OAD MS/MS capabilities
• Acquity C18 BEH column (2.1×100 mm, 1.7 µm) for reversed-phase separation
• Microwave discharge radical source for generation of O, OH, and H radicals